Medopharm — Erythromycin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Erythromycin · $3.0M export value · DGFT Verified
Medopharm is the #1 Indian exporter of Erythromycin with $3.0M in export value and 61 verified shipments. Medopharm holds a 3.8% market share in Erythromycin exports across 14 countries. The company exports 21 pharmaceutical products worth $50.2M across 10 therapeutic categories.
Medopharm — Erythromycin Export Profile: Buyers & Destinations
Where Does Medopharm Export Erythromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $471.9K | 16 | 20.1% |
| AFGHANISTAN | $300.0K | 6 | 12.8% |
| UNITED ARAB EMIRATES | $260.1K | 13 | 11.1% |
| TANZANIA | $250.0K | 5 | 10.6% |
| DENMARK | $234.2K | 5 | 10.0% |
| YEMEN | $179.9K | 4 | 7.7% |
| GERMANY | $172.9K | 5 | 7.4% |
| ZIMBABWE | $150.0K | 3 | 6.4% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $78.4K | 3 | 3.3% |
| LIBERIA | $53.2K | 2 | 2.3% |
Medopharm exports Erythromycin to 17 countries. The largest destination is NETHERLANDS accounting for 20.1% of Medopharm's Erythromycin shipments, followed by AFGHANISTAN (12.8%) and UNITED ARAB EMIRATES (11.1%). These destinations reflect Medopharm's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Erythromycin from Medopharm?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNICEF KABUL | AFGHANISTAN | $300.0K | 6 |
| MEDICAL STORES DEPARTMENT. | TANZANIA | $250.0K | 5 |
| UNICEF SANAA | YEMEN | $179.9K | 4 |
| MINISTRY OF HEALTH AND CHILDWELFARE | ZIMBABWE | $150.0K | 3 |
| IMRES POBOX | NETHERLANDS | $135.5K | 5 |
| UNICEF SUPPLY DIVISION | DENMARK | $134.2K | 3 |
| UNICEF SUPPLY DIVISION. | DENMARK | $100.0K | 2 |
| M/S. IMRES | NETHERLANDS | $89.1K | 3 |
| PHILCO PHARMA E K. | GERMANY | $88.9K | 2 |
| PHILCO PHARMA E K | GERMANY | $84.0K | 3 |
Medopharm supplies Erythromycin to 30 buyers globally. The largest buyer is UNICEF KABUL (AFGHANISTAN), followed by MEDICAL STORES DEPARTMENT. (TANZANIA) and UNICEF SANAA (YEMEN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Erythromycin Export Value and How Much Does Medopharm Contribute?
India exported $19.0M worth of Erythromycin through 3,939 shipments from 368 suppliers to 135 countries, serving 992 buyers globally. Medopharm contributes $3.0M to this total, accounting for 3.8% of India's Erythromycin exports. Medopharm ships Erythromycin to 17 countries through 30 buyers.
What Is the Average Shipment Value for Medopharm's Erythromycin Exports?
Medopharm's average Erythromycin shipment value is $50.0K per consignment, based on 61 shipments totaling $3.0M. The largest destination is NETHERLANDS (20.1% of Medopharm's Erythromycin exports).
How Does Medopharm Compare to Other Indian Erythromycin Exporters?
Medopharm ranks #1 among 368 Indian Erythromycin exporters with a 3.8% market share. The top 3 exporters are MEDOPHARM ($3.0M), S KANT HEALTHCARE LIMITED ($2.8M), MEDREICH LIMITED ($2.1M). Medopharm processed 61 shipments to 14 destination countries.
What Erythromycin Formulations Does Medopharm Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ERYTHROMYCIN STEARATE TABLETS BP 250MG | $432.4K | 13 |
| ERYTHROMYCIN STEARATE TABLETS BP 250MG (70000 X 10 X 10) - BOX | $200.0K | 4 |
| ERYTHROMYCIN STEARATE TABLETS BP 500MG ( | $137.1K | 5 |
| ERYTHROMYCIN STEARATE TABLETS BP 250MG ( | $128.5K | 4 |
| ERYTHROMYCIN STEARATE TABLETS BP 250MG (47388 X 10 X 10 ) -BOX | $100.0K | 2 |
| PHILCO ERY 500 (ERYTHROMYCIN STEARATE TABLETS BP 500MG) (6000 X 12 X 10) - BOX | $88.9K | 2 |
| ERYTHROMYCIN STEARATE TABLETS BP 250MG (12000 X 10 X 10) - BOX | $79.9K | 2 |
| ERYTHROMYCIN STEARATE TABLETS BP 500MG 1020 X 50 X 10 - BOX | $59.0K | 2 |
| ERYTHROMYCIN STEARATE TABLETS BP 500MG 2040 X 50 X 10 BOX | $50.0K | 1 |
| ERYTHROMYCIN STEARATE TABLETS BP 250MG 30000 X 10 X 10 - BOX | $50.0K | 1 |
Medopharm exports 45 distinct Erythromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERYTHROMYCIN STEARATE TABLETS BP 250MG with 13 shipments worth $432.4K.
How Does Medopharm Compare to Nearest Erythromycin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MEDOPHARM ★ | $3.0M | 61 | 14 | $50.0K |
| 4 | S KANT HEALTHCARE LIMITED | $2.8M | 94 | 20 | $29.9K |
| 5 | MEDREICH LIMITED | $2.1M | 96 | 4 | $22.1K |
Medopharm ranks #1 among 368 Indian Erythromycin exporters. Average shipment value of $50.0K compared to the market average of $51.7K. The closest competitors by value are S KANT HEALTHCARE LIMITED and MEDREICH LIMITED.
Which Indian Ports Ship Erythromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 513 | 13.0% |
| DELHI AIR CARGO ACC (INDEL4) | 394 | 10.0% |
| SAHAR AIR | 377 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 370 | 9.4% |
| JNPT/ NHAVA SHEVA SEA | 234 | 5.9% |
| DELHI AIR | 227 | 5.8% |
| JNPT | 176 | 4.5% |
| Bombay Air | 99 | 2.5% |
What Other Antibiotics Products Does Medopharm Export?
Medopharm also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medopharm's Erythromycin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medopharm. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions have particularly impacted trade corridors through the Persian Gulf and the Strait of Hormuz, vital for India's drug shipments. (pharmaceuticalcommerce.com)
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of 100% tariffs on branded or patented pharmaceutical products by the US in October 2025 poses a significant challenge. While generic drugs may remain largely unaffected, companies like Medopharm must navigate these policy shifts carefully. (itisbl.com)
The recent India–European Union Free Trade Agreement, concluded in January 2026, offers a favorable development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing market access for Indian companies in the EU. (en.wikipedia.org)
Medopharm — Regulatory Compliance & Quality Standards
India's pharmaceutical industry has made significant strides in regulatory compliance, with the country surpassing the US in the number of FDA-registered generic manufacturing sites as of 2024. This achievement reflects improved adherence to international quality standards, a critical factor for exporters like Medopharm. (business-standard.com)
However, the industry faces challenges related to quality compliance, as evidenced by incidents involving contaminated products. Maintaining rigorous quality control measures is essential for sustaining global trust and market access. (economictimes.indiatimes.com)
About Medopharm
Medopharm exports 21 products worth $50.2M. Beyond Erythromycin, top products include Amoxicillin, Metronidazole, Paracetamol, Albendazole, Ciprofloxacin. View the complete Medopharm profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erythromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Erythromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medopharm matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 73 individual customs records matching Medopharm exporting Erythromycin, covering 45 formulations to 17 countries via 30 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 135+ countries, 992+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Erythromycin Export Data from Medopharm
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medopharm's Erythromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medopharm
Full Company Profile →
21 products · $50.2M total trade · 10 categories
Erythromycin Stats
Company Overview
Top Products by Medopharm
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medopharm.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erythromycin. For current shipment-level data, contact TransData Nexus.